BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.

Highlights Beijing Aosaikang Pharmaceutical Co., Ltd.

Equities

002755

CNE100001X92

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 20/05/2024 am IST			5-day change	1st Jan Change
10.78 ^CNY	-0.46%		-2.18%	-0.37%

10/05	Aosaikang Pharma's Unit Gets Nod to Market Isavuconazole Sulfate for Injection	MT
28/04	Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aosaikang Pharma's Unit Gets Nod to Market Isavuconazole Sulfate for Injection	10/05	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	28/04	CI
Beijing Aosaikang Pharma's Unit Gets Nod to Market Delafloxacin for Injection	05/03	MT
Aosaikang Pharmaceutical Registers Breast Cancer Drug	23/01	MT
Aosaikang Pharmaceutical's Unit Gets Nod for Two Drugs	17/01	MT
Aosaikang Pharmaceutical's Unit Gets Nod to Trial ASKC202 Tablets	13/11	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
Aosaikang Pharmaceutical's Unit Gets Nod to Test Gastric Cancer Drug	17/23/17	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/23/30	CI
Aosaikang Pharma's Unit Gets Nod to Amend Instructions for Heart Drug	07/23/07	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Aosaikang Pharma Registers Three Drugs	24/23/24	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/22/30	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	28/22/28	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2021, Payable on June 20, 2022	11/22/11	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021	24/22/24	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021	06/22/06	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/22/29	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. cancelled the acquisition of Jiangsu Vedkang Medical Science and Technology Co., Ltd. from Changzhou Beiruishi Enterprise Management Co., Ltd., Changzhou Yisiyuan Enterprise Management Co., Ltd., Zhuang Xiaojin and Miao Donglin.	17/22/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Beijing Aosaikang Pharmaceutical Co., Ltd.

Equities

002755

CNE100001X92

Highlights

Filters